Why It Matters
On July 11, 2026, the Ministry of Commerce (MOFCOM), in coordination with the National Development and Reform Commission (NDRC), the Ministry of Science and Technology, and seven other central government agencies, jointly released the “2026 Measures to Facilitate Foreign Investment in Science and Technology Enterprises” — an eight-point policy package designed to channel foreign capital into China’s strategic technology sectors. The document, published on MOFCOM’s English-language portal on July 14, marks the most significant opening of China’s technology investment landscape since the 2020 Foreign Investment Law implementing regulations took effect.
The timing is deliberate. China’s H1 2026 economic data released the same week showed high-tech manufacturing growing at 12.1%, but foreign direct investment (FDI) into technology sectors declined 8.4% year-on-year in the first half — a divergence that Chinese policymakers are now moving to correct. The new measures target four bottleneck areas that foreign tech investors have consistently identified as barriers: equity caps, data access, talent mobility, and intellectual property protection.
For foreign venture capital firms, technology companies evaluating China expansion, and multinational R&D centers, these measures create genuine new entry points — but only for those who understand the eligibility criteria and application sequences. The policy is an invitation, not an open door.
The Details: 8 Measures, 4 Priority Areas
Equity and ownership relaxation (Measures 1-2). Foreign investors in “designated strategic technology sub-sectors” can now hold majority equity stakes — up to 75% — in Chinese technology enterprises, relaxing the previous 50% ceiling that applied to most technology categories. The sub-sectors explicitly named in the NDRC supplementary guidance include: AI foundation models and training infrastructure, quantum computing components, advanced semiconductor packaging and testing, biotech therapeutic platforms, and green hydrogen production technology. National security-sensitive sectors (semiconductor fabrication above 28nm, satellite communications, encryption technology) remain under the 50% cap.
Cross-border data facilitation (Measures 3-4). Foreign-invested technology enterprises in nine designated pilot zones — Beijing Zhongguancun, Shanghai Zhangjiang, Shenzhen Qianhai, Guangzhou Nansha, Suzhou Industrial Park, Hefei, Chengdu, Xi’an, and Wuhan Optics Valley — can apply for a “Technology R&D Data Green Channel” that streamlines cross-border data transfer approvals for R&D data, clinical trial results, and software development data. The processing time is reduced to 15 working days from the standard 45-90 days under the general data export regime. This directly addresses the bottleneck that delayed numerous multinational pharmaceutical and AI research programs in 2024-2025.
Talent and visa facilitation (Measures 5-6). Senior technology executives and lead researchers in foreign-invested sci-tech enterprises can now apply for 5-year multiple-entry R-visas (previously limited to 1-year terms). Dependents receive matching visas automatically. A streamlined “Green Path” for foreign talent working in the nine pilot zones reduces work permit processing from 25 working days to 7 working days. Companies with annual R&D expenditure above 50 million yuan qualify for an expedited “corporate talent quota” covering up to 20 foreign employees per entity per year.
Intellectual property (Measures 7-8). The China National Intellectual Property Administration (CNIPA) has established dedicated IP enforcement desks in the nine pilot zones for foreign-invested technology enterprises. Patent examination for foreign-filed applications in AI, biotech, and semiconductor areas is prioritized with a target of 12-month first-office-action (down from the standard 18-24 months). Additionally, a fast-track trade secret protection mechanism allows foreign companies to file injunctions against suspected IP theft within 72 hours of a complaint, compared to the standard 15-day civil procedure timeline.
Sector eligibility screening. Crucially, these measures are not blanket liberalization. Companies must pass a “Strategic Technology Contribution Assessment” administered by the local Municipal Science and Technology Bureau, evaluating the enterprise’s technology transfer commitment, domestic R&D expenditure as a percentage of revenue (minimum 5% threshold), and local hiring ratios (at least 60% Chinese national employees in technical roles). The application is reviewed within 30 working days and is renewable every two years.
What You Should Do
Map your technology to eligible sub-sectors. Review your China technology operations against the NDRC’s designated sub-sector list (AI foundation models, quantum computing, advanced semiconductor packaging, biotech therapeutics, green hydrogen). If your technology falls into one of these five categories, the 75% equity cap is your most significant new strategic lever — consider restructuring your China subsidiary ownership before competitors do.
Select a pilot-zone location. The nine designated pilot zones offer varying advantages for different technology profiles: Beijing Zhongguancun for AI and quantum computing (closest to the Chinese Academy of Sciences ecosystem), Shanghai Zhangjiang for biotech and semiconductor (strongest contract research and manufacturing infrastructure), Shenzhen Qianhai for hardware-AI integration (fastest product development cycle, plus the CIT/IIT incentives discussed above). Apply in the zone most aligned with your technology type.
Prepare the Strategic Technology Contribution Assessment. This is the gatekeeper document for accessing all 8 measures. Assemble documentation showing: your enterprise’s technology transfer record in China, audited R&D expenditure (target above 5% of China revenue), local technology hiring pipeline, and a commitment letter detailing three-year technology cooperation targets. Engage a Chinese law firm with NDRC filing experience — the assessment process has procedural nuances that vary by pilot zone.
One Data Point
The number to remember: 75% — the new equity ceiling for foreign investors in designated strategic technology sub-sectors, up from 50%. For a foreign AI company investing 200 million yuan in a Chinese joint venture, that difference means controlling board seats, technology roadmap decisions, and profit repatriation timelines. It is the single biggest structural change in China’s technology foreign investment framework in six years.
Where to Go From Here
For context on foreign technology investment rules in China, read Can Foreign Biotech Companies Own 100% of a Drug Manufacturing Facility?. For a view on technology sector opportunities in China’s industrial transition, see The Smart Grid Manufacturing Opportunity in China.
— China Gateway 360 —
Remote China market entry support, built around execution.
